BioNexus Gene Lab (BGLC) Other Non-Current Assets (2018 - 2026)

BioNexus Gene Lab's Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 4.05% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 4.05% YoY), while the FY2025 annual figure was $1.6 million, up 4.22% from the prior year.
• Other Non-Current Assets came in at $1.6 million for Q1 2026 at BioNexus Gene Lab, up from $1.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $3.3 million in Q1 2024 to a low of $849744.0 in Q2 2022.
• A 5-year average of $1.7 million and a median of $1.5 million in 2022 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets jumped 119.91% in 2024 and tumbled 54.95% in 2025, its largest moves.
• BioNexus Gene Lab's Other Non-Current Assets stood at $1.5 million in 2022, then decreased by 6.33% to $1.4 million in 2023, then grew by 5.58% to $1.5 million in 2024, then gained by 4.22% to $1.6 million in 2025, then rose by 0.88% to $1.6 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.6 million, $1.6 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison